UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Systemic α-synuclein injection triggers selective neuronal pathology as seen in patients with Parkinson's disease

Molecular psychiatry, 2021-02, Vol.26 (2), p.556-567

2021

Volltextzugriff (PDF)

Transvascular delivery of α-synuclein preformed fibrils, using the RVG9R delivery system, generates α-synuclein pathology in the duodenal myenteric plexus of non-transgenic rats

Molecular psychiatry, 2021-02, Vol.26 (2), p.365-365

2021

Volltextzugriff (PDF)

Tricyclic cell-penetrating peptides for efficient delivery of functional antibodies into cancer cells

Nature chemistry, 2022-03, Vol.14 (3), p.284-293

2022

Volltextzugriff (PDF)

Design, Synthesis, and Evaluation of an 18F-Labeled Radiotracer Based on Celecoxib-NBD for Positron Emission Tomography (PET) Imaging of Cyclooxygenase-2 (COX-2)

ChemMedChem, 2015-10, Vol.10 (10), p.1635-1640

2015

Volltextzugriff (PDF)

Abstract 3616: Towards intracellular targeting: Cytosolic delivery using TAT-trimers

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.3616-3616

2019

Volltextzugriff (PDF)

Peptides for trans‐blood–brain barrier delivery

Journal of labelled compounds & radiopharmaceuticals, 2023-07, Vol.66 (9), p.237-248

2023

Volltextzugriff (PDF)

An overview of in vitro and in vivo techniques for characterization of intranasal protein and peptide formulations for brain targeting

International journal of pharmaceutics, 2024-04, Vol.654, p.123922-123922, Article 123922

2024

Volltextzugriff (PDF)

Insulin Delivery to the Brain via the Nasal Route: Unraveling the Potential for Alzheimer's Disease Therapy

Drug delivery and translational research, 2024-07, Vol.14 (7), p.1776-1793

2024

Volltextzugriff (PDF)

Impact of structural alterations on the radiopharmacological profile of 18F-labeled pyrimidines as cyclooxygenase-2 (COX-2) imaging agents

Nuclear medicine and biology, 2018-07, Vol.62-63, p.9-17

2018

Volltextzugriff (PDF)

Impact of structural alterations on the radiopharmacological profile of ^sup 18^F-labeled pyrimidines as cyclooxygenase-2 (COX-2) imaging agents

Nuclear medicine and biology, 2018-07, Vol.62/63, p.9

2018

Volltextzugriff (PDF)

Abstract 5816: An effective delivery platform for nucleic acid therapeutics: Enhanced cancer cell internalization and endosomal escape

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.5816-5816

2024

Volltextzugriff (PDF)

A fluorescent molecular imaging probe with selectivity for soluble tau aggregated protein

Chemical science (Cambridge), 2020-05, Vol.11 (18), p.4773-4778

2020

Volltextzugriff (PDF)

Pyrimidine-based fluorescent COX-2 inhibitors: synthesis and biological evaluationElectronic supplementary information (ESI) available. See DOI: 10.1039/c6ob00493h

2016-07

Volltextzugriff (PDF)

Design, Synthesis, and Evaluation of an (18)F-Labeled Radiotracer Based on Celecoxib-NBD for Positron Emission Tomography (PET) Imaging of Cyclooxygenase-2 (COX-2)

ChemMedChem, 2015-10, Vol.10 (10), p.1635-1640

2015

Volltextzugriff (PDF)

VCAM-1 targeted alpha-particle therapy for early brain metastases

Neuro-oncology (Charlottesville, Va.), 2020-03, Vol.22 (3), p.357-368

2020

Volltextzugriff (PDF)

Oligonucleotide-Functionalized Gold Nanoparticles for Synchronous Telomerase Inhibition, Radiosensitization, and Delivery of Theranostic Radionuclides

Molecular pharmaceutics, 2021-10, Vol.18 (10), p.3820-3831

2021

Volltextzugriff (PDF)

An 111In-labelled bis-ruthenium(ii) dipyridophenazine theranostic complex: mismatch DNA binding and selective radiotoxicity towards MMR-deficient cancer cells

Chemical science (Cambridge), 2020-09, Vol.11 (33), p.8936-8944

2020

Volltextzugriff (PDF)

Pyrimidine-based fluorescent COX-2 inhibitors: synthesis and biological evaluation

Organic & biomolecular chemistry, 2016-01, Vol.14 (30), p.7250-7257

2016

Volltextzugriff (PDF)

Systemic [alpha]-synuclein injection triggers selective neuronal pathology as seen in patients with Parkinson's disease

Molecular psychiatry, 2021-02, Vol.26 (2), p.556

2021

Volltextzugriff (PDF)

Transvascular delivery of [alpha]-synuclein preformed fibrils, using the RVG9R delivery system, generates [alpha]-synuclein pathology in the duodenal myenteric plexus of non-transgenic rats

Molecular psychiatry, 2021-02, Vol.26 (2), p.365

2021

Volltextzugriff (PDF)

An 111In-labelled bis-ruthenium(ii) dipyridophenazine theranostic complex: mismatch DNA binding and selective radiotoxicity towards MMR-deficient cancer cells† †Electronic supplementary information (ESI) available. See DOI: 10.1039/d0sc02825h

Chemical science (Cambridge), 2020-08, Vol.11 (33), p.8936-8944

2020

Volltextzugriff (PDF)

An 111 In-labelled bis-ruthenium(ii) dipyridophenazine theranostic complex: mismatch DNA binding and selective radiotoxicity towards MMR-deficient cancer cells

Chemical science (Cambridge), 2020-09, Vol.11 (33), p.8936-8944

2020

Volltextzugriff (PDF)

An In-labelled bis-ruthenium() dipyridophenazine theranostic complex: mismatch DNA binding and selective radiotoxicity towards MMR-deficient cancer cells

Chemical science (Cambridge), 2020-09, Vol.11 (33), p.8936-8944

2020

Volltextzugriff (PDF)

Design and synthesis of [125I]Pyricoxib: A novel 125I-labeled cyclooxygenase-2 (COX-2) inhibitors

Bioorganic & medicinal chemistry letters, 2016-03, Vol.26 (6), p.1516-1520

2016

Volltextzugriff (PDF)

Design and synthesis of [(125)I]Pyricoxib: A novel (125)I-labeled cyclooxygenase-2 (COX-2) inhibitors

Bioorganic & medicinal chemistry letters, 2016-03, Vol.26 (6), p.1516-1520

2016

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(34)

Sprache

Englisch
(33)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Systemic α-synuclein injection triggers selective neuronal pathology as seen in patients with Parkinson's disease

Transvascular delivery of α-synuclein preformed fibrils, using the RVG9R delivery system, generates α-synuclein pathology in the duodenal myenteric plexus of non-transgenic rats

Tricyclic cell-penetrating peptides for efficient delivery of functional antibodies into cancer cells

Design, Synthesis, and Evaluation of an 18F-Labeled Radiotracer Based on Celecoxib-NBD for Positron Emission Tomography (PET) Imaging of Cyclooxygenase-2 (COX-2)

Abstract 3616: Towards intracellular targeting: Cytosolic delivery using TAT-trimers

Peptides for trans‐blood–brain barrier delivery

An overview of in vitro and in vivo techniques for characterization of intranasal protein and peptide formulations for brain targeting

Insulin Delivery to the Brain via the Nasal Route: Unraveling the Potential for Alzheimer's Disease Therapy

Impact of structural alterations on the radiopharmacological profile of 18F-labeled pyrimidines as cyclooxygenase-2 (COX-2) imaging agents

Impact of structural alterations on the radiopharmacological profile of ^sup 18^F-labeled pyrimidines as cyclooxygenase-2 (COX-2) imaging agents

Abstract 5816: An effective delivery platform for nucleic acid therapeutics: Enhanced cancer cell internalization and endosomal escape

A fluorescent molecular imaging probe with selectivity for soluble tau aggregated protein

Pyrimidine-based fluorescent COX-2 inhibitors: synthesis and biological evaluationElectronic supplementary information (ESI) available. See DOI: 10.1039/c6ob00493h

Design, Synthesis, and Evaluation of an (18)F-Labeled Radiotracer Based on Celecoxib-NBD for Positron Emission Tomography (PET) Imaging of Cyclooxygenase-2 (COX-2)

VCAM-1 targeted alpha-particle therapy for early brain metastases

Oligonucleotide-Functionalized Gold Nanoparticles for Synchronous Telomerase Inhibition, Radiosensitization, and Delivery of Theranostic Radionuclides

An 111In-labelled bis-ruthenium(ii) dipyridophenazine theranostic complex: mismatch DNA binding and selective radiotoxicity towards MMR-deficient cancer cells

Pyrimidine-based fluorescent COX-2 inhibitors: synthesis and biological evaluation

Systemic [alpha]-synuclein injection triggers selective neuronal pathology as seen in patients with Parkinson's disease

Transvascular delivery of [alpha]-synuclein preformed fibrils, using the RVG9R delivery system, generates [alpha]-synuclein pathology in the duodenal myenteric plexus of non-transgenic rats

An 111In-labelled bis-ruthenium(ii) dipyridophenazine theranostic complex: mismatch DNA binding and selective radiotoxicity towards MMR-deficient cancer cells† †Electronic supplementary information (ESI) available. See DOI: 10.1039/d0sc02825h

An 111 In-labelled bis-ruthenium(ii) dipyridophenazine theranostic complex: mismatch DNA binding and selective radiotoxicity towards MMR-deficient cancer cells

An In-labelled bis-ruthenium() dipyridophenazine theranostic complex: mismatch DNA binding and selective radiotoxicity towards MMR-deficient cancer cells

Design and synthesis of [125I]Pyricoxib: A novel 125I-labeled cyclooxygenase-2 (COX-2) inhibitors

Design and synthesis of [(125)I]Pyricoxib: A novel (125)I-labeled cyclooxygenase-2 (COX-2) inhibitors

Suchergebnisse filtern